| Earnings Per Share |
Basic and diluted EPS calculations are detailed as follows (in thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 27, 2025 |
|
|
|
|
|
|
Weighted-
Average Shares
(Denominator) |
|
|
|
|
| Net income per basic common share |
|
$ |
148,923 |
|
|
|
59,528 |
|
|
$ |
2.50 |
|
| Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities |
|
|
— |
|
|
|
94 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income per diluted common share |
|
$ |
148,923 |
|
|
|
59,622 |
|
|
$ |
2.50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended September 28, 2024 |
|
| |
|
|
|
|
Weighted-
Average Shares
(Denominator) |
|
|
|
|
| Net income per basic common share |
|
$ |
161,503 |
|
|
|
59,367 |
|
|
$ |
2.72 |
|
| Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities |
|
|
— |
|
|
|
137 |
|
|
|
(0.01 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income per diluted common share |
|
$ |
161,503 |
|
|
|
59,504 |
|
|
$ |
2.71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Nine Months Ended September 27, 2025 |
|
| |
|
|
|
|
Weighted-
Average Shares
(Denominator) |
|
|
|
|
| Net income per basic common share |
|
$ |
417,415 |
|
|
|
59,496 |
|
|
$ |
7.02 |
|
| Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities |
|
|
— |
|
|
|
160 |
|
|
|
(0.02 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income per diluted common share |
|
$ |
417,415 |
|
|
|
59,656 |
|
|
$ |
7.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Nine Months Ended September 28, 2024 |
|
| |
|
|
|
|
Weighted-
Average Shares
(Denominator) |
|
|
|
|
| Net income per basic common share |
|
$ |
406,436 |
|
|
|
59,314 |
|
|
$ |
6.85 |
|
| Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities |
|
|
— |
|
|
|
157 |
|
|
|
(0.02 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income per diluted common share |
|
$ |
406,436 |
|
|
|
59,471 |
|
|
$ |
6.83 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| The Company had 390 thousand and 92 thousand stock options that were antidilutive due to having higher exercise prices than the Company’s average stock price during the three and nine months ended September 27, 2025, respectively. For both the three and nine months ended September 28, 2024, the Company had 130 thousand stock options that were antidilutive. These securities were not included in the computation of diluted EPS. The effect of dilutive securities was calculated using the treasury stock method.
|